Development of an Integrated Bioprocess for Production of NK-92 Cells for Immunotherapy

Contact

Application Notes

Request Information

Development of an Integrated Bioprocess for Production of NK-92 Cells for Immunotherapy

January 2014

Anti-cancer NK-92 lymphocytes are promising for application in immunotherapies. This application note explores a comprehensive workflow for producing clinical-grade NK-92 cells, using Nikon’s BioStation CT to monitor NK-92 phenotype and potency.

Download 4.34MB

Select Your Region and Language

Products and Promotions may differ based on your selected Region.

Americas

Europe & Africa

Development of an Integrated Bioprocess for Production of NK-92 Cells for Immunotherapy

Objective Selector

Learn

More About Nikon Systems

Customer Interviews and Research

Special Interest

Development of an Integrated Bioprocess for Production of NK-92 Cells for Immunotherapy

Related Products:

Select Your Region and Language

Americas

Europe & Africa

Japan

Korea

China

Asia, Oceania & Middle East

お問い合わせ[]